ICE Canola Midday: Stronger Oilseeds Providing a Boost
WINNIPEG, Manitoba--Intercontinental Exchange canola futures were higher at midday Monday, buoyed by a rally in the oilseeds.
There were sharp gains in the Chicago soy complex and in European rapeseed, with more modest increases for Malaysian palm oil. Crude oil prices turned a pinch lower taking some support away from the vegetable oils.
The November canola contract poked above C$600 per metric ton earlier in Monday's session. An analyst commented that if the November doesn't close at that level that would be seen as a "technical failure."
He added that adverse conditions in other parts of the world are supportive of Chicago soybeans with spillover finding its way into canola.
As for the Prairies, the analyst said the eastern half is to be warmer than normal in the coming days with the western half near normal.
The Canadian dollar was advancing by late Monday morning with the loonie rising to 74.12 U.S. cents compared to Friday's close of 73.72.
Approximately 35,000 canola contracts were traded as of 11:35 a.m. EDT, with prices in Canadian dollars per metric ton:
Price Change Canola Nov 591.50 up 2.60 Jan 603.10 up 4.00 Mar 614.90 up 5.40 May 622.90 up 5.00
Source: Commodity News Service Canada, news@marketsfarm.com
(END) Dow Jones Newswires
September 23, 2024 12:01 ET (16:01 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk